FDA accepts two applications for generic weight loss drugs amid international competition as well as issues of patents and ...

Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...

Monthly sales of GLP-1 weight-loss drugs in India dipped to ₹227 crore in June from a record ₹236 crore in May, signaling a ...

The GLP-1 weight-loss and diabetes drug market stabilizes as generics gain traction, with innovators maintaining steady sales ...

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

The proposed framework would bring manufacturers and suppliers of printed pharmaceutical packaging materials under drug laws ...

India’s drugmakers have a global repute, and they supply nearly half of all generic medicines sold at retail pharmacy outlets ...

Eli Lilly currently holds a patent on both drugs through 2036.

Generic medications are approved by the FDA because they have the same safety and effectiveness profiles as the name-brand or ...

Many people believe that name-brand medications are better than their generic versions. But is Tylenol truly more effective ...

Granules India wins FDA sole first-to-file status for sodium oxybate extended-release ANDA, a generic of Alkermes’ LUMRYZ, ...

The Supreme Court ruling in Hikma v. Amarin clarifies that inducement requires clear, active encouragement, not just vague or ...